An official American thoracic society workshop report: Evaluation and management of asthma in the elderly

Annals of the American Thoracic Society

Volumn 13, Issue 11, 2016, Pages 2064-2077

  Skloot, Gwen S ^a   Busse, Paula J ^b   Braman, Sidney S ^b   Kovacs, Elizabeth J ^b   Dixon, Anne E ^b   Vaz Fragoso, Carlos A ^b   Scichilone, Nicola ^b   Prakash, Y S ^b   Pabelick, Christina M ^b   Mathur, Sameer K ^b   Hanania, Nicola A ^b   Moore, Wendy C ^b   Gibson, Peter G ^b   Zieman, Susan ^b   Ragless, Betina B ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Aging; Immunosenescence; Lung function; Phenotype; Reactive airways disease

Indexed keywords

BIOLOGICAL MARKER;

AGED; AGING; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE DEFECT; COMORBIDITY; EVALUATION STUDY; HUMAN; IMMUNE FUNCTION TEST; MEDICAL SOCIETY; MORBIDITY; MORTALITY; MOTOR PERFORMANCE; PHENOTYPE; POLYPHARMACY; RESPIRATORY TRACT INFLAMMATION; RISK ASSESSMENT; DIFFERENTIAL DIAGNOSIS; DISEASE MANAGEMENT; IMMUNOSENESCENCE; LUNG; PATHOPHYSIOLOGY; UNITED STATES;

AGED; AGING; ASTHMA; BIOMARKERS; COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; DISEASE MANAGEMENT; HUMANS; IMMUNOSENESCENCE; LUNG; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SOCIETIES, MEDICAL; UNITED STATES;

EID: 84995480052     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201608-658ST     Document Type: Article

References (175)

1. Vincent GK, Velkoff VA, U.S. Census Bureau. The next four decades: the older population in the United States: 2010 to 2050. Washington, D.C.: U.S. Deptartment of Commerce, Economics, and Statistics Administration, U.S. Census Bureau; 2010.
2. United Nations. Department of Economic and Social Affairs Population Division. World Population Prospects: The 2012 Revision, key findings and advance tables. Working paper no. ESA/P/WP.227. New York, NY: United Nations; 2013.
3. Braman SS, Hanania NA. Asthma in older adults. Clin Chest Med 2007;28:685-702, v.
4. Mathur SK. Allergy and asthma in the elderly. Semin Respir Crit Care Med 2010;31:587-595.
5. Milgrom H, Huang H. Allergic disorders at a venerable age: a minireview. Gerontology 2014;60:99-107.
6. Kannan JA, Bernstein DI, Bernstein CK, Ryan PH, Bernstein JA, Villareal MS, Smith AM, Lenz PH, Epstein TG. Significant predictors of poor quality of life in older asthmatics. Ann Allergy Asthma Immunol 2015;115:198-204.
7. Moorman JE, Akinbami LJ, Bailey CM, Zahran HS, King ME, Johnson CA, Liu X. National surveillance of asthma: United States, 2001- 2010. Vital Health Stat 3 2012;35:1-58.
8. Tsai CL, Lee WY, Hanania NA, Camargo CA Jr. Age-related differences in clinical outcomes for acute asthma in the United States, 2006-2008. J Allergy Clin Immunol 2012;129: 1252-1258.e1.
9. Gonzalez-Garcia M, Caballero A, Jaramillo C, Maldonado D, Torres- Duque CA. Prevalence, risk factors and underdiagnosis of asthma and wheezing in adults 40 years and older: a population-based study. J Asthma 2015;52:823-830.
10. Hanania NA, King MJ, Braman SS, Saltoun C, Wise RA, Enright P, Falsey AR, Mathur SK, Ramsdell JW, Rogers L, et al.; Asthma in Elderly workshop participants. Asthma in the elderly: current understanding and future research needs - A report of a National Institute on Aging (NIA) workshop. J Allergy Clin Immunol 2011;128: S4-S24.
11. Akgün KM, Crothers K, Pisani M. Epidemiology and management of common pulmonary diseases in older persons. J Gerontol A Biol Sci Med Sci 2012;67:276-291.
12. Dodge RR, Burrows B. The prevalence and incidence of asthma and asthma-like symptoms in a general population sample. Am Rev Respir Dis 1980;122:567-575.
13. Burrows B, Barbee RA, Cline MG, Knudson RJ, Lebowitz MD. Characteristics of asthma among elderly adults in a sample of the general population. Chest 1991;100:935-942.
14. Burrows B, Lebowitz MD, Barbee RA, Cline MG. Findings before diagnoses of asthma among the elderly in a longitudinal study of a general population sample. J Allergy Clin Immunol 1991;88: 870-877.
15. Bellia V, Battaglia S, Catalano F, Scichilone N, Incalzi RA, Imperiale C, Rengo F. Aging and disability affect misdiagnosis of COPD in elderly asthmatics: the SARA study. Chest 2003;123: 1066-1072.
16. Gibson PG, McDonald VM, Marks GB. Asthma in older adults. Lancet 2010;376:803-813.
17. Bousquet J, Khaltaev N. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. Geneva, Switzerland: World Health Organization; 2007.
18. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, et al.; Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001;56: M146-M156.
19. Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 1995;332: 556-561.
20. Studenski S, Perera S, Patel K, Rosano C, Faulkner K, Inzitari M, Brach J, Chandler J, Cawthon P, Connor EB, et al. Gait speed and survival in older adults. JAMA 2011;305:50-58.
21. Fried TR, Vaz Fragoso CA, Rabow MW. Caring for the older person with chronic obstructive pulmonary disease. JAMA 2012;308: 1254-1263.
22. Blackwell DL, Lucas JW, Clarke TC. Summary health statistics for U.S. Adults: national health interview survey, 2012. Vital Health Stat 10 2014;260:1-161.
23. Jia H, Lubetkin EI. Impact of nine chronic conditions for US adults aged 65 years and older: an application of a hybrid estimator of quality-adjusted life years throughout remainder of lifetime. Qual Life Res 2016;25:1921-1929.
24. Greenberg S (for the Administration on Aging, U.S. Department of Health and Human Services). A profile of older Americans: 2010 [accessed 2015 Sep]. Available from: http://www.aoa.acl.gov/
25. Ornstein KA, Leff B, Covinsky KE, Ritchie CS, Federman AD, Roberts L, Kelley AS, Siu AL, Szanton SL. Epidemiology of the homebound population in the United States. JAMA Intern Med 2015;175: 1180-1186.
26. Cigolle CT, Langa KM, Kabeto MU, Tian Z, Blaum CS. Geriatric conditions and disability: the Health and Retirement Study. Ann Intern Med 2007;147:156-164.
27. Brault MW. Americans with disabilities (2010). Current Population Reports. U.S. Department of Commerce Economics and Statistics Administration, U.S. Census Bureau. 2012;(July 2012 Issue): 70-131.
28. Joo JH, Lim GI, Seo MJ, Park SJ, Lee JH, Uh ST, Kim YH, Park CS. Perception of wheezing in the elderly asthmatics. Korean J Intern Med 2001;16:260-264.
29. Allen SC, Khattab A. The airflow resistance sensing threshold during tidal breathing rises in old age in patients with asthma. Age Ageing 2012;41:557-560.
30. Connolly MJ, Crowley JJ, Charan NB, Nielson CP, Vestal RE. Reduced subjective awareness of bronchoconstriction provoked by methacholine in elderly asthmatic and normal subjects as measured on a simple awareness scale. Thorax 1992;47:410-413.
31. Levy BR. Mind matters: cognitive and physical effects of aging selfstereotypes. J Gerontol B Psychol Sci Soc Sci 2003;58:203-211.
32. Yáñez A, Cho SH, Soriano JB, Rosenwasser LJ, Rodrigo GJ, Rabe KF, Peters S, Niimi A, Ledford DK, Katial R, et al. Asthma in the elderly: what we know and what we have yet to know. World Allergy Organ J 2014;7:8.
33. Hochhegger B, Meirelles GS, Irion K, Zanetti G, Garcia E, Moreira J, Marchiori E. The chest and aging: radiological findings. J Bras Pneumol 2012;38:656-665.
34. Vaz Fragoso CA, Gill TM. Respiratory impairment and the aging lung: a novel paradigm for assessing pulmonary function. J Gerontol A Biol Sci Med Sci 2012;67:264-275.
35. Miller MR. Structural and physiological age-associated changes in aging lungs. Semin Respir Crit Care Med 2010;31:521-527.
36. Janssens JP, Pache JC, Nicod LP. Physiological changes in respiratory function associated with ageing. Eur Respir J 1999;13: 197-205.
37. Lowery EM, Brubaker AL, Kuhlmann E, Kovacs EJ. The aging lung. Clin Interv Aging 2013;8:1489-1496.
38. Sharma G, Goodwin J. Effect of aging on respiratory system physiology and immunology. Clin Interv Aging 2006;1:253-260.
39. Janssens JP. Aging of the respiratory system: impact on pulmonary function tests and adaptation to exertion. Clin Chest Med 2005;26: 469-484, vi-vii.
40. Sorino C, Battaglia S, Scichilone N, Pedone C, Antonelli-Incalzi R, Sherrill D, Bellia V. Diagnosis of airway obstruction in the elderly: contribution of the SARA study. Int J Chron Obstruct Pulmon Dis 2012;7:389-395.
41. Scichilone N, Messina M, Battaglia S, Catalano F, Bellia V. Airway hyperresponsiveness in the elderly: prevalence and clinical implications. Eur Respir J 2005;25:364-375.
42. Gelb AF, Yamamoto A, Verbeken EK, Nadel JA. Unraveling the pathophysiology of the asthma-COPD overlap syndrome: unsuspected mild centrilobular emphysema is responsible for loss of lung elastic recoil in never smokers with asthma with persistent expiratory airflow limitation. Chest 2015;148:313-320.
43. Gelb AF, Licuanan J, Shinar CM, Zamel N. Unsuspected loss of lung elastic recoil in chronic persistent asthma. Chest 2002;121:715-721.
44. Inoue H, Niimi A, Takeda T, Matsumoto H, Ito I, Matsuoka H, Jinnai M, Otsuka K, Oguma T, Nakaji H, et al. Pathophysiological characteristics of asthma in the elderly: a comprehensive study. Ann Allergy Asthma Immunol 2014;113:527-533.
45. Senhorini A, Ferreira DS, Shiang C, Silva LF, Dolhnikoff M, Gelb AF, Mauad T. Airway dimensions in fatal asthma and fatal COPD: overlap in older patients. COPD 2013;10:348-356.
46. Bai TR, Cooper J, Koelmeyer T, ParéPD, Weir TD. The effect of age and duration of disease on airway structure in fatal asthma. Am J Respir Crit Care Med 2000;162:663-669.
47. James AL, Palmer LJ, Kicic E, Maxwell PS, Lagan SE, Ryan GF, Musk AW. Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking. Am J Respir Crit Care Med 2005;171:109-114.
48. Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci 2014;69:S4-S9.
49. Annema JT, Sparrow D, O'Connor GT, Rijcken B, Koëter GH, Postma DS, Weiss ST. Chronic respiratory symptoms and airway responsiveness to methacholine are associated with eosinophilia in older men: the Normative Aging Study. Eur Respir J 1995;8:62-69.
50. Mathur SK, Schwantes EA, Jarjour NN, Busse WW. Age-related changes in eosinophil function in human subjects. Chest 2008;133: 412-419.
51. Nyenhuis SM, Schwantes EA, Mathur SK. Characterization of leukotrienes in a pilot study of older asthma subjects. Immun Ageing 2010;7:8.
52. Busse PJ, Zhang TF, Srivastava K, Schofield B, Li XM. Effect of ageing on pulmonary inflammation, airway hyperresponsiveness and T and B cell responses in antigen-sensitized and -challenged mice. Clin Exp Allergy 2007;37:1392-1403.
53. Meyer KC, Rosenthal NS, Soergel P, Peterson K. Neutrophils and low-grade inflammation in the seemingly normal aging human lung. Mech Ageing Dev 1998;104:169-181.
54. Meyer KC, Soergel P. Variation of bronchoalveolar lymphocyte phenotypes with age in the physiologically normal human lung. Thorax 1999;54:697-700.
55. Pignatti P, Ragnoli B, Radaeli A, Moscato G, Malerba M. Age-related increase of airway neutrophils in older healthy nonsmoking subjects. Rejuvenation Res 2011;14:365-370.
56. Sapey E, Greenwood H, Walton G, Mann E, Love A, Aaronson N, Insall RH, Stockley RA, Lord JM. Phosphoinositide 3-kinase inhibition restores neutrophil accuracy in the elderly: toward targeted treatments for immunosenescence. Blood 2014;123:239-248.
57. Brooks CR, Gibson PG, Douwes J, Van Dalen CJ, Simpson JL. Relationship between airway neutrophilia and ageing in asthmatics and non-asthmatics. Respirology 2013;18:857-865.
58. Nyenhuis SM, Schwantes EA, Evans MD, Mathur SK. Airway neutrophil inflammatory phenotype in older subjects with asthma. J Allergy Clin Immunol 2010;125:1163-1165.
59. Wood LG, Baines KJ, Fu J, Scott HA, Gibson PG. The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma. Chest 2012;142:86-93.
60. Moore WC, Hastie AT, Li X, Li H, Busse WW, Jarjour NN, Wenzel SE, Peters SP, Meyers DA, Bleecker ER; National Heart, Lung, and Blood Institute's Sever Asthma Research Program. Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis. J Allergy Clin Immunol 2014; 133:1557-1563.e5.
61. Birmingham JM, Gillespie VL, Srivastava K, Li XM, Busse PJ. Influenza A infection enhances antigen-induced airway inflammation and hyperresponsiveness in young but not aged mice. Clin Exp Allergy 2014;44:1188-1199.
62. Brandenberger C, Li N, Jackson-Humbles DN, Rockwell CE, Wagner JG, Harkema JR. Enhanced allergic airway disease in old mice is associated with a Th17 response. Clin Exp Allergy 2014;44:1282-1292.
63. Nair P, Aziz-Ur-Rehman A, Radford K. Therapeutic implications of 'neutrophilic asthma'. Curr Opin Pulm Med 2015;21:33-38.
64. Kane B, Fowler SJ, Niven R. Refractory asthma: beyond step 5, the role of new and emerging adjuvant therapies. Chron Respir Dis 2015;12:69-77.
65. Hartl D, Koller B, Mehlhorn AT, Reinhardt D, Nicolai T, Schendel DJ, Griese M, Krauss-Etschmann S. Quantitative and functional impairment of pulmonary CD41CD25hi regulatory T cells in pediatric asthma. J Allergy Clin Immunol 2007;119:1258-1266.
66. Kearley J, Barker JE, Robinson DS, Lloyd CM. Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD41CD251 regulatory T cells is interleukin 10 dependent. J Exp Med 2005;202:1539-1547.
67. Kearley J, Robinson DS, Lloyd CM. CD41CD251 regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling. J Allergy Clin Immunol 2008;122:617-624.e6.
68. Ling EM, Smith T, Nguyen XD, Pridgeon C, Dallman M, Arbery J, Carr VA, Robinson DS. Relation of CD41CD251 regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004;363:608-615.
69. Vale-Pereira S, Todo-Bom A, Geraldes L, Schmidt-Weber C, Akdis CA, Mota-Pinto A. FoxP3, GATA-3 and T-bet expression in elderly asthma. Clin Exp Allergy 2011;41:490-496.
70. Birmingham JM, Patil S, Li XM, Busse PJ. The effect of oral tolerance on the allergic airway response in younger and aged mice. J Asthma 2013;50:122-132.
71. Murray MA, Chotirmall SH. The impact of immunosenescence on pulmonary disease. Mediators Inflamm 2015;2015:692546.
72. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, Saretzki G, Carter NP, Jackson SP. A DNA damage checkpoint response in telomere-initiated senescence. Nature 2003;426:194-198.
73. Gilson E, Géli V. How telomeres are replicated. Nat Rev Mol Cell Biol 2007;8:825-838.
74. Passos JF, Simillion C, Hallinan J, Wipat A, von Zglinicki T. Cellular senescence: unravelling complexity. Age (Dordr) 2009;31:353-363.
75. Kyoh S, Venkatesan N, Poon AH, Nishioka M, Lin TY, Baglole CJ, Eidelman DH, Hamid Q. Are leukocytes in asthmatic patients aging faster? A study of telomere length and disease severity. J Allergy Clin Immunol 2013;132:480-482.e2.
76. Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X, D'Agostino R Jr, Castro M, Curran-Everett D, Fitzpatrick AM, et al.; National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med 2010;181:315-323.
77. Fajt ML, Wenzel SE. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care. J Allergy Clin Immunol 2015;135:299-310, quiz 311.
78. Menzella F, Lusuardi M, Galeone C, Zucchi L. Tailored therapy for severe asthma. Multidiscip Respir Med 2015;10:1.
79. Agache IO. From phenotypes to endotypes to asthma treatment. Curr Opin Allergy Clin Immunol 2013;13:249-256.
80. Kontakioti E, Domvri K, Papakosta D, Daniilidis M. HLA and asthma phenotypes/endotypes: a review. Hum Immunol 2014;75:930-939.
81. Wenzel S. Severe asthma: from characteristics to phenotypes to endotypes. Clin Exp Allergy 2012;42:650-658.
82. Park HW, Song WJ, Kim SH, Park HK, Kim SH, Kwon YE, Kwon HS, Kim TB, Chang YS, Cho YS, et al. Classification and implementation of asthma phenotypes in elderly patients. Ann Allergy Asthma Immunol 2015;114:18-22.
83. Baptist AP, Ross JA, Clark NM. Older adults with asthma: does age of asthma onset make a difference? J Asthma 2013;50:836-841.
84. Song WJ, Sintobin I, Sohn KH, Kang MG, Park HK, Jo EJ, Lee SE, Yang MS, Kim SH, Park HK, et al. Staphylococcal enterotoxin IgE sensitization in late-onset severe eosinophilic asthma in the elderly. Clin Exp Allergy 2016;46:411-421.
85. Al-Alawi M, Hassan T, Chotirmall SH. Advances in the diagnosis and management of asthma in older adults. Am J Med 2014;127: 370-378.
86. Reddel HK, Bateman ED, Becker A, Boulet LP, Cruz AA, Drazen JM, Haahtela T, Hurd SS, Inoue H, de Jongste JC, et al. A summary of the new GINA strategy: a roadmap to asthma control. Eur Respir J 2015;46:622-639.
87. Diaz-Guzman E, Mannino DM. Airway obstructive diseases in older adults: from detection to treatment. J Allergy Clin Immunol 2010; 126:702-709.
88. European Community Respiratory Health Survey II Steering Committee. The European Community Respiratory Health Survey II. Eur Respir J 2002;20:1071-1079.
89. Siroux V, Boudier A, Bousquet J, Bresson JL, Cracowski JL, Ferran J, Gormand F, Just L, Le Moual N, Morange S, et al. Phenotypic determinants of uncontrolled asthma. J Allergy Clin Immunol 2009; 124:681-687.e3.
90. Ackermann-Liebrich U, Kuna-Dibbert B, Probst-Hensch NM, Schindler C, Felber Dietrich D, Stutz EZ, Bayer-Oglesby L, Baum F, Brändli O, Brutsche M, et al.; SAPALDIA Team. Follow-up of the Swiss Cohort Study on Air Pollution and Lung Diseases in Adults (SAPALDIA 2) 1991-2003: methods and characterization of participants. Soz Praventivmed 2005;50:245-263.
91. Boudier A, Curjuric I, Basagaña X, Hazgui H, Anto JM, Bousquet J, Bridevaux PO, Dupuis-Lozeron E, Garcia-Aymerich J, Heinrich J, et al. Ten-year follow-up of cluster-based asthma phenotypes in adults: a pooled analysis of three cohorts. Am J Respir Crit Care Med 2013;188:550-560.
92. Cuttitta G, Cibella F, Bellia V, Grassi V, Cossi S, Bucchieri S, Bonsignore G. Changes in FVC during methacholine-induced bronchoconstriction in elderly patients with asthma: bronchial hyperresponsiveness and aging. Chest 2001;119:1685-1690.
93. Ducharme ME, Prince P, Hassan N, Nair P, Boulet LP. Expiratory flows and airway inflammation in elderly asthmatic patients. Respir Med 2011;105:1284-1289.
94. Renwick DS, Connolly MJ. The relationship between age and bronchial responsiveness: evidence from a population survey. Chest 1999;115:660-665.
95. Vaz Fragoso CA, McAvay G, Van Ness PH, Casaburi R, Jensen RL, MacIntyre N, Gill TM, Yaggi HK, Concato J. Phenotype of normal spirometry in an aging population. Am J Respir Crit Care Med 2015; 192:817-825.
96. Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, Enright PL, Hankinson JL, Ip MS, Zheng J, et al.; ERS Global Lung Function Initiative. Multi-ethnic reference values for spirometry for the 3-95- yr age range: the global lung function 2012 equations. Eur Respir J 2012;40:1324-1343.
97. Bellia V, Battaglia S, Matera MG, Cazzola M. The use of bronchodilators in the treatment of airway obstruction in elderly patients. Pulm Pharmacol Ther 2006;19:311-319.
98. Luoto JA, Elmståhl S, Wollmer P, Pihlsgård M. Incidence of airflow limitation in subjects 65-100 years of age. Eur Respir J 2016;47: 461-472.
99. Allen SC, Ragab S. Ability to learn inhaler technique in relation to cognitive scores and tests of praxis in old age. Postgrad Med J 2002;78:37-39.
100. Allen SC, Yeung P. Inability to draw intersecting pentagons as a predictor of unsatisfactory spirometry technique in elderly hospital inpatients. Age Ageing 2006;35:304-306.
101. Bellia V, Pistelli R, Catalano F, Antonelli-Incalzi R, Grassi V, Melillo G, Olivieri D, Rengo F. Quality control of spirometry in the elderly: the SA.R.A. study. SAlute Respiration nell'Anziano = Respiratory Health in the Elderly. Am J Respir Crit Care Med 2000;161:1094-1100.
102. Melbye H, Medbø A, Crockett A. The FEV1/FEV6 ratio is a good substitute for the FEV1/FVC ratio in the elderly. Prim Care Respir J 2006;15:294-298.
103. Bhatt SP, Kim YI, Wells JM, Bailey WC, Ramsdell JW, Foreman MG, Jensen RL, Stinson DS, Wilson CG, Lynch DA, et al. FEV(1)/FEV(6) to diagnose airflow obstruction: comparisons with computed tomography and morbidity indices. Ann Am Thorac Soc 2014;11: 335-341.
104. Bozek A, Filipowski M, Fischer A, Jarzab J. Characteristics of atopic bronchial asthma in seniors over 80 years of age. Biomed Res Int 2013;2013:689782.
105. Porsbjerg CM, Gibson PG, Pretto JJ, Salome CM, Brown NJ, Berend N, King GG. Relationship between airway pathophysiology and airway inflammation in older asthmatics. Respirology 2013;18: 1128-1134.
106. Langley SJ, Goldthorpe S, Craven M, Morris J, Woodcock A, Custovic A. Exposure and sensitization to indoor allergens: association with lung function, bronchial reactivity, and exhaled nitric oxide measures in asthma. J Allergy Clin Immunol 2003;112:362-368.
107. Dweik RA, Sorkness RL, Wenzel S, Hammel J, Curran-Everett D, Comhair SA, Bleecker E, Busse W, Calhoun WJ, Castro M, et al.; National Heart, Lung, and Blood Institute Severe Asthma Research Program. Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma. Am J Respir Crit Care Med 2010;181:1033-1041.
108. National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol 2007;120: S94-S138.
109. Battaglia S, Basile M, Spatafora M, Scichilone N. Are asthmatics enrolled in randomized trials representative of real-life outpatients? Respiration 2015;89:383-389.
110. NAEPP (National Heart, Lung, and Blood Institute). Working Group on Asthma in the Elderly. Consideration for diagnosing and managing asthma in the elderly. Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute; 1996.
111. Stupka E, deShazo R. Asthma in seniors: part 1. Evidence for underdiagnosis, undertreatment, and increasing morbidity and mortality. Am J Med 2009;122:6-11.
112. Enright PL, McClelland RL, Newman AB, Gottlieb DJ, Lebowitz MD; Cardiovascular Health Study Research Group. Underdiagnosis and undertreatment of asthma in the elderly. Chest 1999;116:603-613.
113. Parameswaran K, Hildreth AJ, Chadha D, Keaney NP, Taylor IK, Bansal SK. Asthma in the elderly: underperceived, underdiagnosed and undertreated; a community survey. Respir Med 1998;92: 573-577.
114. O'Conor R, Wolf MS, Smith SG, Martynenko M, Vicencio DP, Sano M, Wisnivesky JP, Federman AD. Health literacy, cognitive function, proper use, and adherence to inhaled asthma controller medications among older adults with asthma. Chest 2015;147: 1307-1315.
115. Sofianou A, Martynenko M, Wolf MS, Wisnivesky JP, Krauskopf K, Wilson EA, Goel MS, Leventhal H, Halm EA, Federman AD. Asthma beliefs are associated with medication adherence in older asthmatics. J Gen Intern Med 2013;28:67-73.
116. Bouwmeester C, Kraft J, Bungay KM. Optimizing inhaler use by pharmacist-provided education to community-dwelling elderly. Respir Med 2015;109:1363-1368.
117. Battaglia S, Benfante A, Scichilone N. Asthma in the older adult: presentation, considerations and clinical management. Expert Rev Clin Immunol 2015;11:1297-1308.
118. The safety of inactivated influenza vaccine in adults and children with asthma. N Engl J Med 2001;345:1529-1536.
119. Lu PJ, Euler GL, Callahan DB. Influenza vaccination among adults with asthma: findings from the 2007 BRFSS survey. Am J Prev Med 2009;37:109-115.
120. Panda A, Qian F, Mohanty S, van Duin D, Newman FK, Zhang L, Chen S, Towle V, Belshe RB, Fikrig E, et al. Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J Immunol 2010;184:2518-2527.
121. Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 2005;366:1165-1174.
122. Hanania NA, Sockrider M, Castro M, Holbrook JT, Tonascia J, Wise R, Atmar RL; American Lung Association Asthma Clinical Research Centers. Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy. J Allergy Clin Immunol 2004;113:717-724.
123. Lingner H, Ernst S, Grobhennig A, Djahangiri N, Scheub D, Wittmann M, Schultz K. Asthma control and health-related quality of life one year after inpatient pulmonary rehabilitation: the ProKAR Study. J Asthma 2015;52:614-621.
124. Trevor JL, Bhatt SP, Wells JM, Kirkpatrick d, Schumann C, Hitchcock J, Dransfield MT. Benefits of completing pulmonary rehabilitation in patients with asthma. J Asthma 2015;52:969-973.
125. Rochester CL, Fairburn C, Crouch RH. Pulmonary rehabilitation for respiratory disorders other than chronic obstructive pulmonary disease. Clin Chest Med 2014;35:369-389.
126. Renolleau-Courtois D, Lamouroux-Delay A, Delpierre S, Badier M, Lagier-Tessonnier F, Palot A, Gouitaa M, Tummino C, Charpin D, Molinari N, et al. Home-based respiratory rehabilitation in adult patients with moderate or severe persistent asthma. J Asthma 2014;51:552-558.
127. Baptist AP, Deol BB, Reddy RC, Nelson B, Clark NM. Age-specific factors influencing asthma management by older adults. Qual Health Res 2010;20:117-124.
128. McDonald VM, Simpson JL, Higgins I, Gibson PG. Multidimensional assessment of older people with asthma and COPD: clinical management and health status. Age Ageing 2011;40:42-49.
129. Gibson PG, Simpson JL, Saltos N. Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 2001;119:1329-1336.
130. Buist AS, Vollmer WM, Wilson SR, Frazier EA, Hayward AD. A randomized clinical trial of peak flow versus symptom monitoring in older adults with asthma. Am J Respir Crit Care Med 2006;174:1077-1087.
131. Korenblat PE, Kemp JP, Scherger JE, Minkwitz MC, Mezzanotte W. Effect of age on response to zafirlukast in patients with asthma in the Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT). Ann Allergy Asthma Immunol 2000;84:217-225.
132. Baptist AP, Ross JA, Yang Y, Song PX, Clark NM. A randomized controlled trial of a self-regulation intervention for older adults with asthma. J Am Geriatr Soc 2013;61:747-753.
133. Baptist AP, Talreja N, Clark NM. Asthma education for older adults: results from the National Asthma Survey. J Asthma 2011;48: 133-138.
134. Jarvis S, Ind PW, Shiner RJ. Inhaled therapy in elderly COPD patients: time for re-evaluation? Age Ageing 2007;36:213-218.
135. Connolly MJ. Ageing, late-onset asthma and the beta-adrenoceptor. Pharmacol Ther 1993;60:389-404.
136. Connolly MJ, Crowley JJ, Charan NB, Nielson CP, Vestal RE. Impaired bronchodilator response to albuterol in healthy elderly men and women. Chest 1995;108:401-406.
137. Bellia V, Pedone C, Catalano F, Zito A, Davì E, Palange S, Forastiere F, Incalzi RA. Asthma in the elderly: mortality rate and associated risk factors for mortality. Chest 2007;132:1175-1182.
138. Gupta P, O'Mahony MS. Potential adverse effects of bronchodilators in the treatment of airways obstruction in older people: recommendations for prescribing. Drugs Aging 2008;25:415-443.
139. Collamati A, Martone AM, Poscia A, Brandi V, Celi M, Marzetti E, Cherubini A, Landi F. Anticholinergic drugs and negative outcomes in the older population: from biological plausibility to clinical evidence. Aging Clin Exp Res 2016;28:25-35.
140. Hartert TV, Togias A, Mellen BG, Mitchel EF, Snowden MS, Griffin MR. Underutilization of controller and rescue medications among older adults with asthma requiring hospital care. J Am Geriatr Soc 2000; 48:651-657.
141. Sin DD, Tu JV. Underuse of inhaled steroid therapy in elderly patients with asthma. Chest 2001;119:720-725.
142. Sin DD, Tu JV. Inhaled corticosteroid therapy reduces the risk of rehospitalization and all-cause mortality in elderly asthmatics. Eur Respir J 2001;17:380-385.
143. Etminan M, Sadatsafavi M, Ganjizadeh Zavareh S, Takkouche B, FitzGerald JM. Inhaled corticosteroids and the risk of fractures in older adults: a systematic review and meta-analysis. Drug Saf 2008; 31:409-414.
144. Battaglia S, Cardillo I, Lavorini F, Spatafora M, Scichilone N. Safety considerations of inhaled corticosteroids in the elderly. Drugs Aging 2014;31:787-796.
145. Gershon A, Croxford R, Calzavara A, To T, Stanbrook MB, Upshur R, Stukel TA. Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease. JAMA Intern Med 2013;173:1175-1185.
146. Gershon AS, Campitelli MA, Croxford R, Stanbrook MB, To T, Upshur R, Stephenson AL, Stukel TA. Combination long-acting b-agonists and inhaled corticosteroids compared with long-acting b-agonists alone in older adults with chronic obstructive pulmonary disease. JAMA 2014;312:1114-1121.
147. Bermingham M, O'Callaghan E, Dawkins I, Miwa S, Samsudin S, McDonald K, Ledwidge M. Are beta2-agonists responsible for increased mortality in heart failure? Eur J Heart Fail 2011;13:885-891.
148. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J; TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007;356:775-789.
149. Kerstjens HA, Engel M, Dahl R, Paggiaro P, Beck E, Vandewalker M, Sigmund R, Seibold W, Moroni-Zentgraf P, Bateman ED. Tiotropium in asthma poorly controlled with standard combination therapy. N Engl J Med 2012;367:1198-1207.
150. Creticos P, Knobil K, Edwards LD, Rickard KA, Dorinsky P. Loss of response to treatment with leukotriene receptor antagonists but not inhaled corticosteroids in patients over 50 years of age. Ann Allergy Asthma Immunol 2002;88:401-409.
151. Maykut RJ, Kianifard F, Geba GP. Response of older patients with IgE-mediated asthma to omalizumab: a pooled analysis. J Asthma 2008;45:173-181.
152. Korn S, Schumann C, Kropf C, Stoiber K, Thielen A, Taube C, Buhl R. Effectiveness of omalizumab in patients 50 years and older with severe persistent allergic asthma. Ann Allergy Asthma Immunol 2010;105:313-319.
153. Asero R. Efficacy of injection immunotherapy with ragweed and birch pollen in elderly patients. Int Arch Allergy Immunol 2004;135: 332-335.
154. Cox L, Nelson H, Lockey R, Calabria C, Chacko T, Finegold I, Nelson M, Weber R, Bernstein DI, Blessing-Moore J, et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol 2011;127:S1-S55.
155. Chen W, Lynd LD, FitzGerald JM, Marra CA, Rousseau R, Sadatsafavi M. The added effect of comorbidity on health-related quality of life in patients with asthma. Qual Life Res 2015;24:2507-2517.
156. van Manen JG, Bindels PJ, IJzermans CJ, van der Zee JS, Bottema BJ, SchadéE. Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40. J Clin Epidemiol 2001;54:287-293.
157. Diette GB, Krishnan JA, Dominici F, Haponik E, Skinner EA, Steinwachs D, Wu AW. Asthma in older patients: factors associated with hospitalization. Arch Intern Med 2002;162:1123-1132.
158. Zhang T, Carleton BC, Prosser RJ, Smith AM. The added burden of comorbidity in patients with asthma. J Asthma 2009;46: 1021-1026.
159. Chan WL, Yang KP, Chao TF, Huang CC, Huang PH, Chen YC, Chen TJ, Lin SJ, Chen JW, Leu HB. The association of asthma and atrial fibrillation: a nationwide population-based nested case-control study. Int J Cardiol 2014;176:464-469.
160. Hardin M, Cho M, McDonald ML, Beaty T, Ramsdell J, Bhatt S, van Beek EJ, Make BJ, Crapo JD, Silverman EK, et al. The clinical and genetic features of COPD-asthma overlap syndrome. Eur Respir J 2014;44:341-350.
161. Whitters D, Stockley RA. Bronchiectasis in older patients with chronic obstructive pulmonary disease: prevalence, diagnosis and therapeutic management. Drugs Aging 2013;30:215-225.
162. Reed CE. The natural history of asthma. J Allergy Clin Immunol 2006; 118:543-548, quiz 549-550.
163. Oguzulgen IK, Kervan F, Ozis T, Turktas H. The impact of bronchiectasis in clinical presentation of asthma. South Med J 2007;100:468-471.
164. Pite H, Pereira AM, Morais-Almeida M, Nunes C, Bousquet J, Fonseca JA. Prevalence of asthma and its association with rhinitis in the elderly. Respir Med 2014;108:1117-1126.
165. Jarvis D, Newson R, Lotvall J, Hastan D, Tomassen P, Keil T, Gjomarkaj M, Forsberg B, Gunnbjornsdottir M, Minov J, et al. Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in Europe. Allergy 2012;67:91-98.
166. Schatz M, Zeiger RS, Yang SJ, Chen W, Sajjan S, Allen-Ramey F, Camargo CA Jr. Prospective study on the relationship of obesity to asthma impairment and risk. J Allergy Clin Immunol Pract 2015;3: 560-565.e1.
167. Mold JW, Reed LE, Davis AB, Allen ML, Decktor DL, Robinson M. Prevalence of gastroesophageal reflux in elderly patients in a primary care setting. Am J Gastroenterol 1991;86:965-970.
168. Shimizu Y, Dobashi K, Kusano M, Mori M. Different gastoroesophageal reflux symptoms of middle-aged to elderly asthma and chronic obstructive pulmonary disease (COPD) patients. J Clin Biochem Nutr 2012;50:169-175.
169. Krauskopf KA, Sofianou A, Goel MS, Wolf MS, Wilson EA, Martynenko ME, Halm EA, Leventhal H, Feldman JM, Federman AD, et al. Depressive symptoms, low adherence, and poor asthma outcomes in the elderly. J Asthma 2013;50:260-266.
170. Bozek A, Jarzab J. Adherence to asthma therapy in elderly patients. J Asthma 2010;47:162-165.
171. Bellia V, Catalano F, Scichilone N, Incalzi RA, Spatafora M, Vergani C, Rengo F. Sleep disorders in the elderly with and without chronic airflow obstruction: the SARA study. Sleep 2003;26:318-323.
172. Teodorescu M, Polomis DA, Gangnon RE, Fedie JE, Consens FB, Chervin RD, Teodorescu MC. Asthma control and its relationship with obstructive sleep apnea (OSA) in older adults. Sleep Disord 2013;2013:251567.
173. Onder G, Petrovic M, Tangiisuran B, Meinardi MC, Markito-Notenboom WP, Somers A, Rajkumar C, Bernabei R, van der Cammen TJ. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score. Arch Intern Med 2010;170:1142-1148.
174. Corsonello A, Pedone C, Corica F, Mussi C, Carbonin P, Antonelli Incalzi R; Gruppo Italiano di Farmacovigilanza nell'Anziano (GIFA) Investigators. Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients. Arch Intern Med 2005;165:790-795.
175. Wooten JM. Pharmacotherapy considerations in elderly adults. South Med J 2012;105:437-445.